Johnson & Johnson Announces $5 Billion Share Repurchase Program

NEW BRUNSWICK, N.J., Sept. 14, 2022 – Johnson & Johnson (NYSE: JNJ) today announced that the Board of Directors has authorized the repurchase of up to $5 billion of the company's …

CouponFollow Extension

$5
OFF

Johnson & Johnson Announces $5 Billion Share Repurchase Program

3 weeks from now

NEW BRUNSWICK, N.J., Sept. 14, 2022 – Johnson & Johnson (NYSE: JNJ) today announced that the Board of Directors has authorized the repurchase of up to $5 billion of the company's …

jnj.com

$5
OFF

J&J (JNJ) Announces $5B Stock Repurchase Program, Stock Up

3 weeks from now

Sep 15, 2022 · Johnson & Johnson JNJ announced that its board of directors has authorized a new share buyback plan worth $5 billion. The company also reaffirmed its full-year sales and …

yahoo.com

5%
OFF

Johnson & Johnson Announces $5 Billion Share Repurchase Program

3 weeks from now

Sep 14, 2022 · Johnson & Johnson reaffirms its full-year 2022 adjusted operational sales growth and earnings per share guidance of 6.5% - 7.5% and $10.65 to $10.75 per share, respectively. …

marketscreener.com

$5
OFF

J&J (JNJ) Announces $5B Stock Repurchase Program, Stock Up

3 weeks from now

Sep 15, 2022 · Johnson & Johnson JNJ announced that its board of directors has authorized a new share buyback plan worth $5 billion. The company also reaffirmed its full-year sales and …

nasdaq.com

$5
OFF

Johnson & Johnson Announces $5 Billion Share Repurchase Program

3 weeks from now

Dec 17, 2018 · The company does not expect to incur debt to fund the share repurchase program. Johnson & Johnson reaffirms its full-year 2018 sales and adjusted earnings per share …

prnewswire.com

$5
OFF

J&J Announces $5B Share Repurchase - Massdevice.com

3 weeks from now

Sep 14, 2022 · J&J said the repurchase program announced today has no time limit, and the company can opt to suspend it for periods or even discontinue it. The company had roughly …

massdevice.com

$5
OFF

Johnson & Johnson Sets $5 Billion Stock Buyback Program

3 weeks from now

Sep 14, 2022 · Johnson & Johnson on Wednesday said its board authorized the repurchase of up to $5 billion of common stock. The New Brunswick, N.J., healthcare giant, which had nearly …

marketscreener.com

7%
OFF

Johnson & Johnson Stock Gains After $5 Billion Stock Repurchase …

3 weeks from now

Sep 14, 2022 · Shares of Johnson & Johnson jumped 0.7% in premarket trading Wednesday, after the the pharmaceutical and consumer health products company announced a $5 billion …

marketwatch.com

$5
OFF

Johnson & Johnson Announces $5 Billion Share Repurchase Program

3 weeks from now

Jul 21, 2014 · The repurchase program has no time limit and may be suspended for periods or discontinued at any time. Any shares acquired will be available for general corporate …

jnj.com

$5
OFF

Johnson & Johnson Announces $5 Billion Share Repurchase Program

3 weeks from now

Sep 14, 2022 · The company does not expect to incur debt to fund the share repurchase program. Johnson & Johnson reaffirms its full-year 2022 adjusted operational sales growth and earnings …

firstwordpharma.com

$5
OFF

Why Johnson & Johnson Was Such A Healthy Stock Today

3 weeks from now

Sep 14, 2022 · Before the trading day opened, Johnson & Johnson announced that its board of directors has authorized a $5 billion share repurchase program for the company's common stock.

fool.com

$5
OFF

Johnson & Johnson Announces $5 Billion Share Repurchase …

3 weeks from now

NEW BRUNSWICK, N.J., Dec. 17, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that the Board of Directors has authorized the repurchase of up to $5 billion of the …

biospace.com

$150
OFF

Arcadis. Improving Quality Of Life | Arcadis

3 weeks from now

5 days ago · Arcadis secures share of $150m indefinite delivery, multiple-award task order contract with US Army Corps of Engineers, Tulsa District ... Press Release. Dec 09, 2024. …

arcadis.com

$5
OFF

Johnson & Johnson Announces $5 Billion Share Repurchase Program

3 weeks from now

Sep 14, 2022 · The company does not expect to incur debt to fund the share repurchase program. Johnson & Johnson reaffirms its full-year 2022 adjusted operational sales growth and earnings …

investingnews.com

$5
OFF

Johnson & Johnson Announces $5 Billion Share Repurchase Program

3 weeks from now

Dec 17, 2018 · Johnson & Johnson reaffirms its full-year 2018 sales and adjusted earnings per share guidance of $81.0 to $81.4 billion and $8.13 to $8.18 per share, respectively. About …

jnj.com

$6.33
OFF

Chubb Insurance

3 weeks from now

Chubb news. Chubb Reports Fourth Quarter Per Share Net Income and Core Operating Income of $6.33 and $6.02, Respectively; Consolidated Net Premiums Written of $12.1 Billion, with …

chubb.com

FAQs about Johnson & Johnson Announces $5 Billion Share Repurchase Program Coupon?

Does Johnson & Johnson have a repurchase plan?

NEW BRUNSWICK, N.J.-- ( BUSINESS WIRE )--Johnson & Johnson (NYSE: JNJ) today announced that the Board of Directors has authorized the repurchase of up to $5 billion of the company's common stock. “The last few years have demonstrated the resilience of Johnson & Johnson. ...

Will Johnson & Johnson incur debt to fund the share repurchase program?

The company does not expect to incur debt to fund the share repurchase program. Johnson & Johnson reaffirms its full-year 2022 adjusted operational sales growth and earnings per share guidance of 6.5% - 7.5% and $10.65 to $10.75 per share, respectively. ...

Does Johnson & Johnson JNJ have a buyback plan?

Johnson & Johnson JNJ announced that its board of directors has authorized a new share buyback plan worth $5 billion. The company also reaffirmed its full-year sales and profit targets. J&J’s stock was up 2% on Wednesday in response to the buyback plan. This year so far, J&J’s shares have declined 3.8% compared with the industry’s decline of 4.1%. ...

Why did Johnson & Johnson (JNJ) shares move higher Wednesday?

Johnson & Johnson ( JNJ) - Get Free Report shares moved higher Wednesday after the healthcare and pharmaceutical groupunveiled a new $5 billion share buyback program and reaffirmed its full-year profit targets. ...

How did Johnson & Johnson perform in 2022?

Looking into the 2022 financial year, Johnson & Johnson trimmed its forecast for adjusted earnings to between $10.00 to $10.10 per share, down 25 cents from the higher end of its prior forecast, with sales in the region of $93.3 to $94.3 billion. ...

Is Johnson & Johnson acquiring a biopharmaceutical company?

Johnson & Johnson is acquiring biopharmaceutical company Intra-Cellular Therapies for $14.6 billion. It has an approved depression and schizophrenia treatment that could generate $5 billion in peak sales. The company will expand J&J's pipeline and could pave the way for more growth in the future. ...